PapersPMID:36277954
Does Moringa oleifera Lam. leaves supplementation have an impact on the weight and bone mass index of people living with HIV that are on antiretroviral therapy? A double-blind randomized control trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 6 months
- Dose studied, every finding
- 15 g/day leaf powder sachet, divided into three 5 g portions added to food before eating, 6 months
- Population, every finding
- adults living with HIV in Kano, Nigeria, on tenofovir + lamivudine + efavirenz antiretroviral therapy for at least three months
No finding here moved its endpoint.
What did not
How to read these marks →“Estimate of fixed effects between MOG and COG showed that both the weight (p=0.5556) and BMI (p=0.5145) were not significantly (p>0.05) different over the study period.”
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Adults living with HIV on tenofovir + lamivudine + efavirenz ART, S.S Wali Virology Centre, Aminu Kano Teaching Hospital, Kano, Nigeria; Moringa oleifera leaf powder versus chlorophyll-coloured corn starch placebo
- Participants
- 200
- Comparator
- placebo
- Duration
- 183 days
- Endpoints measured
- 14